Chris Ronne counsels emerging companies and innovative high-growth companies at every stage of their business cycle. Chris has transactional experience spanning technology (including artificial intelligence and machine learning), biotechnology, life sciences and specialty pharmaceuticals, consumer products and retail, financial services and fintech, and telecommunications. He assists clients with angel, venture capital, and growth equity financings, joint ventures, formation advice, and other strategic and outside general counsel matters.
Chris helps startup clients by reviewing their business plans, helping identify appropriate financing sources, and connecting them to various emerging company and venture capital communities. Chris also represents venture capital firms and other investors in connection with strategic investments in private companies.
In addition, Chris represents public and private companies, private equity, individual, and institutional investors in cross-border mergers and acquisitions, financings and strategic investments, and corporate governance matters. Before joining Morgan Lewis, Chris served as an attorney-advisor in the Division of Corporation Finance at the US Securities and Exchange Commission, and he leverages that experience to advise clients with respect to US federal securities laws and corporate governance matters.
While serving in the SEC’s Division of Corporation Finance, Chris reviewed transactional and securities disclosures filed under the Securities Act of 1933, such as IPOs, follow-on offerings, spin-offs, and business combinations, as well as current and periodic reports by public companies filed pursuant to the Securities Exchange Act of 1934.
Listed, The Best Lawyers in America, Ones to Watch, Corporate Governance and Compliance Law, Seattle (2024, 2025)
Listed, The Best Lawyers in America, Ones to Watch, Corporate Governance and Compliance Law, Washington, DC (2023)